Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

INTRODUCTION: Patients with advanced hepatocellular carcinoma have a dismal prognosis; only a subset of patients with advanced HCC will benefit from treatment with immunotherapy. We searched for clinical characteristics predicting exceptional long-term survival in HCC patients treated with immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Monge, Cecilia, Xie, Changqing, Steinberg, Seth M, Greten, Tim F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178695/
https://www.ncbi.nlm.nih.gov/pubmed/34104639
http://dx.doi.org/10.2147/JHC.S311496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178695/
https://www.ncbi.nlm.nih.gov/pubmed/34104639
http://dx.doi.org/10.2147/JHC.S311496

Ejemplares similares